10.13.15
Following its recent acquisition by Consort Medical, Aesica Pharmaceuticals, a global pharmaceutical contract development and manufacturing organization (CDMO), is launching its new brand identity reflecting the alignment and consolidation of the Consort Medical group.
The combination of Aesica and Bespak enables Consort Medical to provide drug and device development, formulation, manufacturing and packaging. The group’s offering comprises advanced delivery technologies, formulation development and drug manufacturing solutions.
Aesica provides API and finished dose formulation development and manufacturing services and Bespak is a developer and manufacturer of drug delivery devices.
The new logo and branding will be adopted across all Consort Medical businesses, creating a consistent identity for all group companies.
The combination of Aesica and Bespak enables Consort Medical to provide drug and device development, formulation, manufacturing and packaging. The group’s offering comprises advanced delivery technologies, formulation development and drug manufacturing solutions.
Aesica provides API and finished dose formulation development and manufacturing services and Bespak is a developer and manufacturer of drug delivery devices.
The new logo and branding will be adopted across all Consort Medical businesses, creating a consistent identity for all group companies.